Impact of a prospective audit and feedback antimicrobial stewardship program at a veterans affairs medical center: A six-point assessment

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Morrill, Haley J ^a,b   Caffrey, Aisling R ^a,b   Gaitanis, Melissa M ^a,c   LaPlante, Kerry L ^a,b,c  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI PSEUDOMONAL AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP PROGRAM; ANTIMICROBIAL THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DRUG COST; DRUG USE; FEMALE; HOSPITAL CARE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; PROCESS METRICS; PUBLIC HOSPITAL; QUASI EXPERIMENTAL STUDY; RAPID TEST; SIDE EFFECT; TREATMENT OUTCOME; VERBAL COMMUNICATION; VERBAL FEEDBACK; MANAGEMENT; MIDDLE AGED; PROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; FEMALE; HOSPITALS, VETERANS; HUMANS; MALE; MANAGEMENT AUDIT; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84961589761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150795     Document Type: Article

References (41)

1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013 Atlanta, GA: CDC; 2013. Available: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/arthreats-2013-508.pdf. Accessed 02 March 2016.
2. The White House. National Action Plan for Combating Antibiotic-Resistant Bacteria. March 2015. Available: https://www.whitehouse.gov/sites/default/files/docs/national-action-plan-for-combating-antibotic-resistant-bacteria.pdf. Accessed 02 March 2016.
3. Lautenbach E, Weiner MG, Nachamkin I, Bilker WB, Sheridan A, Fishman NO. Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infection control and hospital epidemiology. 2006; 27(9):893-900. PMID: 16941312
4. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical infectious diseases. 2009; 49(8):1175-84. doi: 10.1086/605630 PMID: 19739972
5. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infection control and hospital epidemiology. 2008; 29(12):1099-106. doi: 10.1086/592412 PMID: 18973455
6. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ. 2008; 179(8):767-72. doi: 10.1503/cmaj.071812 PMID: 18838451
7. Dellit TH, Owens RC, McGowan JE Jr., Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical infectious diseases. 2007; 44(2):159-77. PMID: 17173212
8. Lesprit P, Landelle C, Brun-Buisson C. Clinical impact of unsolicited post-prescription antibiotic review in surgical and medical wards: a randomized controlled trial. Clinical microbiology and infection. 2013; 19(2):E91-7. doi: 10.1111/1469-0691.12062 PMID: 23153410
9. Camins BC, King MD, Wells JB, Googe HL, Patel M, Kourbatova EV, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infection control and hospital epidemiology. 2009; 30(10):931-8. doi: 10.1086/605924 PMID: 19712032
10. Masia M, Matoses C, Padilla S, Murcia A, Sanchez V, Romero I, et al. Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial. European journal of clinical microbiology & infectious diseases. 2008; 27(7):597-605.
11. Weiss CH, Moazed F, McEvoy CA, Singer BD, Szleifer I, Amaral LA, et al. Prompting physicians to address a daily checklist and process of care and clinical outcomes: a single-site study. American journal of respiratory and critical care medicine. 2011; 184(6):680-6. doi: 10.1164/rccm.201101-0037OC PMID: 21616996
12. Manuel O, Burnand B, Bady P, Kammerlander R, Vansantvoet M, Francioli P, et al. Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards. The Journal of hospital infection. 2010; 74(4):326-31. doi: 10.1016/j.jhin.2009.07.011 PMID: 19712997
13. Elligsen M, Walker SA, Pinto R, Simor A, Mubareka S, Rachlis A, et al. Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis. Infection control and hospital epidemiology. 2012; 33(4):354-61. doi: 10.1086/664757 PMID: 22418630
14. Standiford HC, Chan S, Tripoli M, Weekes E, Forrest GN. Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program. Infection control and hospital epidemiology. 2012; 33(4):338-45. doi: 10.1086/664909 PMID: 22418628
15. Teo J, Kwa AL, Loh J, Chlebicki MP, Lee W. The effect of a whole-system approach in an antimicrobial stewardship programme at the Singapore General Hospital. European journal of clinical microbiology & infectious diseases. 2012; 31(6):947-55.
16. Bornard L, Dellamonica J, Hyvernat H, Girard-Pipau F, Molinari N, Sotto A, et al. Impact of an assisted reassessment of antibiotic therapies on the quality of prescriptions in an intensive care unit. Medecine et maladies infectieuses. 2011; 41(9):480-5. doi: 10.1016/j.medmal.2010.12.022 PMID: 21778026
17. Dunn K, O'Reilly A, Silke B, Rogers T, Bergin C. Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study. International journal of clinical pharmacy. 2011; 33(2):208-14. doi: 10.1007/s11096-010-9475-9 PMID: 21744190
18. Caffrey AR, Noh E, Morrill HJ, LaPlante KL. The Effects of Obesity on the Comparative Effectiveness of Linezolid and Vancomycin in Suspected Methicillin-resistant Staphylococcus aureus Pneumonia. Advances in Pharmacoepidemiology & Drug Safety. 2015; 4(1): 176.
19. Fridkin SK, Srinivasan A. Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States. Clinical infectious diseases. 2014; 58(3):401-6. doi: 10.1093/cid/cit710 PMID: 24162744
20. Centers for Disease Control and Prevention (CDC). National Healthcare Safety Network (NHSN). Antimicrobial Use and Resistance (AUR) Module. January 2014. Available: http://www.cdc.gov/nhsn/PDFs/pscManual/11pscAURcurrent.pdf. Accessed 02 March 2016.
21. Huttner B, Jones M, Huttner A, Rubin M, Samore MH. Antibiotic prescription practices for pneumonia, skin and soft tissue infections and urinary tract infections throughout the US Veterans Affairs system. The Journal of antimicrobial chemotherapy. 2013; 68(10):2393-9. doi: 10.1093/jac/dkt171 PMID: 23681271
22. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infection control and hospital epidemiology. 2010; 31(5):431-55. doi: 10.1086/651706 PMID: 20307191
23. VA Inpatient Evaluation Center (IPEC). Clostridium difficile Data Reporting User Manual: Acute Care Facilities Version 4. February 11, 2014.
24. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in medicine. 1998; 17(19):2265-81. PMID: 9802183
25. Rubin DB. Estimating causal effects from large data sets using propensity scores. Annals of internal medicine. 1997; 127(8 Pt 2)757-63. PMID: 9382394
26. Gillings D, Makuc D, Siegel E. Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. American journal of public Health. 1981; 71(1):38-46. PMID: 7258429
27. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. Journal of clinical pharmacy and therapeutics. 2002; 27(4):299-309. PMID: 12174032
28. Dickey DA. Stationarity Issues in Time Series Models. Available: http://www2.sas.com/proceedings/sugi30/192-30.pdf. Accessed 18 Dec 2015.
29. Dodds Ashley ES, Kaye KS, DePestel DD, Hermsen ED. Antimicrobial stewardship: philosophy versus practice. Clinical infectious diseases. 2014; 59 Suppl 3:S112-21. doi: 10.1093/cid/ciu546 PMID: 25261538
30. Centers for Medicare & Medicaid Services. Hospital Compare data archive. Available: https://data.medicare.gov/data/archives/hospital-compare. Accessed 02 March 2016.
31. Cook PP, Catrou PG, Christie JD, Young PD, Polk RE. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. The Journal of antimicrobial chemotherapy. 2004; 53(5):853-9. PMID: 15044426
32. Septimus E. Antimicrobial stewardship-qualitative and quantitative outcomes: the role of measurement. Current infectious disease reports. 2014; 16(11):433. doi: 10.1007/s11908-014-0433-x PMID: 25230602
33. Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF Jr., et al. A computer-assisted management program for antibiotics and other antiinfective agents. The New England journal of medicine. 1998;338(4):232-8. PMID: 9435330
34. Rhee SM, Stone ND. Antimicrobial stewardship in long-term care facilities. Infectious disease clinics of North America. 2014; 28(2):237-46. doi: 10.1016/j.idc.2014.01.001 PMID: 24857390
35. Bauer KA, Perez KK, Forrest GN, Goff DA. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clinical infectious diseases. 2014; 59 Suppl 3:S134-45. doi: 10.1093/cid/ciu547 PMID: 25261540
36. Rhode Island Department of Health, Division of Infectious Disease & Epidemiology. Influenza Epidemiology Summary Report Rhode Island 2010-2011. Available: http://www.health.ri.gov/publications/surveillance/2011/Influenza.pdf. Accessed 02 March 2016.
37. Rhode Island Department of Health, Division of Infectious Disease & Epidemiology. Influenza Epidemiology Summary Report Rhode Island 2012-2013. Available: http://www.health.ri.gov/publications/surveillance/2013/Influenza.pdf. Accessed 2 March 2016.
38. Huttner B, Jones M, Rubin MA, Neuhauser MM, Gundlapalli A, Samore M. Drugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs medical centers, 2005-2010. PLoS ONE. 2012; 7(5):e36649. doi: 10.1371/journal.pone.0036649 PMID: 22615789
39. Sohn MW, Arnold N, Maynard C, Hynes DM. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006; 4:2. PMID: 16606453
40. Brown SH, Lincoln MJ, Groen PJ, Kolodner RM. VistA - U.S. Department of Veterans Affairs national-scale HIS. Int J Med Inform. 2003; 69(2-3):135-56. PMID: 12810119
41. Maynard C, Chapko MK. Data resources in the Department of Veterans Affairs. Diabetes Care. 2004; 27 Suppl 2:B22-6. PMID: 15113778